CEA is the first of the so-called carcinoembryonic proteins that was discovered in 1965 by Gold and Freeman and is the most widely used marker for gastrointestinal cancer. Although CEA is primarily associated with colorectal cancers, other malignancies that can cause elevated levels of CEA include breast, lung, stomach, pancreas, ovary and other organs

The Fortress Diagnostics CEA can be used for quantitative determination of carcinoembryonic antigen (CEA) concentration in human serum by a microplate immunoenzymometric assay. 

Product Name Number Kit Size
CEA BXE0811A 96T

Request a Quote

Please get in touch to see how we can help

Contact Us Quote

Our website use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy & Cookies Policy